Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
9
Page:
62-77
Author(s):
Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova and Ivan Spicka
Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
84-107
Author(s):
M. W. Lawless, S. Norris, K. J. O'Byrne and S. G. Gray
Potential Novel Targets in Breast Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
148-153
Author(s):
Pranela Rameshwar
Designer Peptides: Learning from Nature
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
675-681
Author(s):
A. Shrivastava, A. D. Nunn and M. F. Tweedle
The Discovery of Antiangiogenic Molecules: A Historical Review
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
345-352
Author(s):
Domenico Ribatti
MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
456-462
Author(s):
R. L. Stallings
Role of Tyrosine Phosphatase Inhibitors in Cancer Treatment with Emphasis on SH2 Domain-Containing Tyrosine Phosphatases (SHPs)
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
212-220
Author(s):
Mahban Irandoust, Timo K. van den Berg, Gertjan J.L. Kaspers and Jacqueline Cloos
Emerging Treatments in Acute Lymphoblastic Leukemia
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
19-31
Author(s):
R. Crazzolara and L. Bendall
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
32-71
Author(s):
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento
Targeted Tumor Therapies at a Glance
Journal:
Current Drug Targets
Volume:
10
Page:
89-93
Author(s):
H. Fuchs and C. Bachran